XML 37 R27.htm IDEA: XBRL DOCUMENT v3.23.2
Going Concern and Summary of Significant Accounting Policies - Additional Information (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Going Concern and Summary of Significant Accounting Policies              
Cash and cash equivalents $ 17,468,088   $ 21,506,582   $ 17,468,088 $ 21,506,582 $ 22,863,520
Net Income (Loss) (6,215,860) $ (5,739,366) $ (7,239,100) $ (7,339,665) (11,955,226) (14,578,765)  
Cash used in operations         (11,673,476) $ (12,883,603)  
Treasury bills 4,493,766       4,493,766    
Cash, uninsured amount $ 12,474,323       $ 12,474,323   $ 22,613,520
Clinical Supply Arrangements              
Going Concern and Summary of Significant Accounting Policies              
Clinical trials, percentage of additional mark-up on cost         10.00%